Codupha (CDP) Chief Accountant Resigns After One Year Amid Board Shake-Up
This Aveluro analysis covers CDP on UPCOM in the Health Care sector. The classified event type is leadership change, with neutral sentiment and a deterministic market-impact score of 5.0/10. Source coverage came from CafeF - Thị trường chứng khoán, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Overview
Codupha Central Pharmaceutical Joint Stock Company (CDP) announced the resignation of Chief Accountant Pham Chi Truc, effective August 25, 2026, citing personal reasons. The move comes amid a series of board-level personnel changes and ahead of an extraordinary shareholder meeting, raising governance concerns for the UPCOM-listed pharmaceutical distributor.
Key Facts
- Pham Chi Truc, born 1975, resigned as Chief Accountant of Codupha (CDP) effective August 25, 2026, exactly one year after his appointment on August 25, 2025.
- Truc previously served as Deputy General Director of Finance at Hau Giang Pharmaceutical (DHG) from July 4, 2020, to July 4, 2021.
- In July 2026, Codupha received resignations from Nguyen Duc Tuan, Head of the Supervisory Board, and Nguyen Thanh Thanh Binh, a member of the Supervisory Board.
- Codupha plans to hold an extraordinary shareholder meeting on September 7, 2026.
- In H1 2026, Codupha reported net revenue of VND 1,293 billion, down 12% year-on-year, while pre-tax profit rose 7.5% to VND 15.6 billion and after-tax profit increased 2.5% to over VND 12 billion.
- CDP shares closed at VND 10,700 on August 18, 2026.
What Happened
Codupha Central Pharmaceutical Joint Stock Company (CDP) announced that Chief Accountant Pham Chi Truc submitted his resignation for personal reasons, effective August 25, 2026. Truc, who holds a bachelor’s degree in finance and accounting, had been appointed to the role on August 25, 2025, with a 12-month term, replacing Nguyen Trieu Ngoc Thuan. His departure comes exactly one year after taking office.
Prior to joining Codupha, Truc had extensive experience in pharmaceutical finance, including a stint as Deputy General Director of Finance at Hau Giang Pharmaceutical (DHG) from July 2020 to July 2021. The resignation follows other board-level changes at Codupha: in July 2026, the company announced the resignations of Nguyen Duc Tuan, Head of the Supervisory Board, and Nguyen Thanh Thanh Binh, a member of the Supervisory Board. Codupha has scheduled an extraordinary shareholder meeting for September 7, 2026.
Market Context
CDP trades on the UPCOM exchange, with shares closing at VND 10,700 on August 18, 2026. The company, a state-origin pharmaceutical distributor, has seen revenue decline 12% in H1 2026 to VND 1,293 billion, though profitability improved slightly. The leadership turnover and upcoming EGM add to governance uncertainty, which may weigh on investor sentiment in the near term.
Strategic Significance
The resignation of the chief accountant, coupled with supervisory board departures, signals potential instability in Codupha’s financial oversight and internal controls. For long-term investors, this raises questions about the company’s governance standards and the direction of its strategic plans, especially as it prepares for an extraordinary shareholder meeting. The meeting could provide clarity on new appointments and strategic initiatives, but until then, the company faces heightened scrutiny.
What to Watch
- Outcome of the extraordinary shareholder meeting on September 7, 2026, including any new appointments or strategic resolutions.
- Announcement of a new chief accountant and other key management positions.
- Codupha’s Q3 2026 financial results to assess whether revenue decline persists and profitability trends continue.
- Any further board or management changes that could signal deeper organizational issues.
- Regulatory filings or disclosures regarding the reasons for the supervisory board resignations.